FDA Import Refusal 112-2192253-9/1/21 — Novartis Pharmaceuticals Corporation
The FDA refused shipment 112-2192253-9/1/21 from Novartis Pharmaceuticals Corporation (United States) on Jul 16, 2006. The refused product falls under Drugs and Biologics — CARBAMAZEPINE (ANALGESIC). Cited charge: 179 This firm has 5 or more other import refusals on record.
Refusal details
- Date
- Jul 16, 2006
- Country
- United States
- Product Category
- Drugs and Biologics
- Product Code
- 60LCB14 CARBAMAZEPINE (ANALGESIC)
- Charges
- 179